At a glance
- Originator Nonindustrial source
- Class Class III antiarrhythmics
- Mechanism of Action Calcium channel antagonists; Potassium channel antagonists; Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 14 Jan 2004 Discontinued - Preclinical for Arrhythmias in China (unspecified route)
- 14 Jan 2000 No-Development-Reported for Arrhythmias in China (Unknown route)
- 23 May 1997 New profile